Tcr2 Therapeutics Inc (TCRR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 41,507 | 61,422 | 31,103 | 31,771 | 29,203 |
| Operating Income | -41,507 | -61,422 | -31,103 | -31,771 | -29,203 |
| Other Income | 1,111 | 1,013 | 510 | 298 | 117 |
| Pre-tax Income | -40,396 | -60,409 | -30,593 | -31,473 | -29,086 |
| Income Tax | 3 | 96 | 1 | 128 | 36 |
| Net Income Continuous | -40,399 | -60,505 | -30,594 | -31,601 | -29,122 |
| Net Income | $-40,399 | $-60,505 | $-30,594 | $-31,601 | $-29,122 |
| EPS Basic Total Ops | -1.03 | -1.56 | -0.79 | -0.82 | -0.76 |
| EPS Basic Continuous Ops | -1.03 | -1.56 | -0.79 | -0.82 | -0.76 |
| EPS Diluted Total Ops | -1.03 | -1.56 | -0.79 | -0.82 | -0.76 |
| EPS Diluted Continuous Ops | -1.03 | -1.56 | -0.79 | -0.82 | -0.76 |
| EPS Diluted Before Non-Recurring Items | -1.03 | -1.56 | -0.79 | -0.82 | -0.76 |
| EBITDA(a) | $-40,892 | $-60,676 | $-30,213 | $-31,067 | $-28,497 |